Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Zepp Health's current 1-Year Share Buyback Ratio was -2.10%.
FRA:ST0's 1-Year Share Buyback Ratio is ranked worse than 57.52% of 1257
companies
in the Hardware industry
Industry Median: -1
vs FRA:ST0: -2.10
Zepp Health (FRA:ST0) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Zepp Health 1-Year Share Buyback Ratio Related Terms
FRA:ST0 vs TKLS, UEIC, AXIL: 1-Year Share Buyback Ratio Comparison
For the Consumer Electronics subindustry, Zepp Health's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zepp Health 1-Year Share Buyback Ratio vs Hardware Industry
For the Hardware industry and Technology sector, Zepp Health's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Zepp Health's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of -2.10 mean?
Zepp Health (FRA:ST0) has a 1-Year Share Buyback Ratio of -2.10 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Zepp Health and its competitors. According to the industry distribution chart, Zepp Health ranks #723 out of 1257 companies in the Hardware industry, placing it in the top 57.5%.
Is Zepp Health's 1-Year Share Buyback Ratio too high?
Zepp Health's current 1-Year Share Buyback Ratio is -2.10. Based on the distribution chart, Zepp Health ranks #723 out of 1257 companies in the Hardware industry, which is below the industry midpoint. Overall, Zepp Health has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's 1-Year Share Buyback Ratio compare to TKLS and UEIC?
According to the Hardware industry distribution chart, Zepp Health ranks #723 out of 1257 companies for 1-Year Share Buyback Ratio. This places Zepp Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Hardware company?
A good 1-Year Share Buyback Ratio depends on the Hardware industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Zepp Health and its competitors. Zepp Health's current 1-Year Share Buyback Ratio is -2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Zepp Health (FRA:ST0) has a current 1-Year Share Buyback Ratio of -2.10. The stock's GF Value™ is €3.34, compared to a current price of €3.68 — trading 10.2% above its estimated fair value. The current 1-Year Share Buyback Ratio is -2.10. Zepp Health's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current 1-Year Share Buyback Ratio is -2.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zepp Health (FRA:ST0) Overvalued in 2026?
Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued.
The current stock price of €3.68 is trading 10.2% above its estimated GF Value™ of €3.34.
Key valuation signals for FRA:ST0:
1-Year Share Buyback Ratio: -2.10
GF Value™: €3.34 vs. price of €3.68 (10.2% above fair value)
No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
59GF Score
Get the complete analysis for FRA:ST0
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ST0 has been successfully added to your 
